This video is featured in the 2024 ESMO Annual Meeting Insights Hub

2024 ESMO Annual Meeting Insights Hub
K

ESMO 2024 Insights: Predicting the Outcomes of Advanced Cutaneous Melanoma Cases Following Discontinuation of Immune Checkpoint Inhibition

By 2024 ESMO Annual Meeting Insights Hub FEATURING Ka-Won Noh, Oana Diana Persa
By 2024 ESMO Annual Meeting Insights Hub FEATURING Ka-Won Noh, Oana Diana Persa
61 views
October 3, 2024
Comments 0
Login to view comments. Click here to Login

2024 ESMO Annual Meeting Insights Hub: Skin Videos

17:12

New

ESMO 2024 Summary: Long-Term Survival Outcomes in Advanced Melanoma …

2024 ESMO Annual Meeting Insights Hub

J. Hassel

7 views
08:45

New

ESMO 2024 Insights: Follow-Up Brain Imaging in Melanoma Patients Wit…

2024 ESMO Annual Meeting Insights Hub

I. Ozdamar

9 views
18:24

ESMO 2024 Summary: Neoadjuvant Immunotherapy as the Future of Melano…

2024 ESMO Annual Meeting Insights Hub

A. van Akkooi

54 views
View All

Recommended

AUTOPLAY
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.8K views
24:14

Advances in the Treatment of Melanoma

Masterclasses in Dermatology

D. Fisher

792 views
35:23

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

S. Patel

750 views
12:46

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Stanford Medicine

A. Betof Warner

998 views
09:26

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Oncology Data Advisor

M. Hadfield

248 views
22:58

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

Tarek Haykal

695 views
11:05

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and R…

2024 ASCO® Annual Meeting Insights Hub

D. Johnson

457 views
14:42

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

Jeff Yorio

507 views
25:29

ASCO® 2024 Summary: "Insights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

O. Hamid

456 views
09:54

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Outcome…

2024 ASCO® Annual Meeting Insights Hub

H. Tawbi

386 views
28:32

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

412 views
18:28

NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…

Vanderbilt University Medical Center (VUMC)

D. Johnson

394 views
09:33

ESMO 2024 Summary: Metastatic Melanoma Highlights

2024 ESMO Annual Meeting Insights Hub

C. Blank

185 views
24:27

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuva…

2024 ASCO® Annual Meeting Insights Hub

Z. Eroglu

323 views
11:27

ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We Been a…

2024 ASCO® Annual Meeting Insights Hub

P. Corrie

275 views
55:10

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

323 views
08:41

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi in Macro…

2024 ASCO® Annual Meeting Insights Hub

C. Blank

261 views
22:27

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

531 views
07:23

Long-Term Side Effects Associated With IO Treatment vs. TT in Adjuva…

Mees Egeler

326 views
12:17

ESMO 2024 Summary: Key Metastatic and Neoadjuvant Melanoma Trials

2024 ESMO Annual Meeting Insights Hub

D. Johnson

162 views